ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver grafts"

  • 2020 American Transplant Congress

    Persistent Fibrinolysis Shutdown in Liver Transplant Recipients is Associated with Early Allograph Dysfunction

    H. B. Moore1, T. Nydam1, J. Pomposelli1, C. Walker1, A. Schulick1, R. Choudhury1, H. Yaffe1, M. Adams2, M. Cohen3, E. Pomfret1

    1University of Colorado, Aurora, CO, 2Childrens Hospital, Aurora, CO, 3Denver Health Medical Center, Denver, CO

    *Purpose: Early allograph dysfunction (EAD) in liver transplantation has been attributed to microvascular thrombosis. Treating grafts at risk of EAD with tissue plasminogen activator (tPA)…
  • 2020 American Transplant Congress

    Development of a Split Liver Machine Perfusion Protocol to Provide Comparative Controls in Assessing Therapeutic Interventions

    J. A. Attard1, L. Wallace1, Y. Boteon1, V. Ronca1, D. Osei-Bordom1, Y. Oo1, H. Mergental2, D. Mirza2, S. Afford1

    1Centre for Liver and Gastroenterology Research, University of Birmingham, Birmingham, United Kingdom, 2Liver Surgery Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom

    *Purpose: Ex situ donor liver machine perfusion is developing into a promising tool to test organ viability prior to transplantation and vehicle to assess novel…
  • 2020 American Transplant Congress

    Acute Rejection in Liver Transplant Recipients is a Rising Predictor of Death and Graft Failure in the Recent Era of Declining Hepatitis C Virus

    T. Bittermann1, D. S. Goldberg2, J. Levitsky3

    1University of Pennsylvania, Philadelphia, PA, 2University of Miami, Miami, FL, 3Northwestern University, Chicago, IL

    *Purpose: Prior to 2013, hepatitis C virus (HCV) played a major role in liver transplant (LT) outcomes, and acute rejection (AR) was found to be…
  • 2020 American Transplant Congress

    Small RNA Extracellular Vesicles Isolated from Liver Perfusate Provides Assessment of Organ Quality and Post Transplantation Graft Function

    A. Bajwa, C. Kuscu, C. Kuscu, A. R. Wolen, J. D. Eason, D. Maluf, V. Mas

    Dept of Surgery, Transplant Research Institute, James D. Eason Transplant Institute, University of Tennessee Health Science Center, Memphis, TN

    *Purpose: Donor quality plays a critical role during IRI and early graft outcomes. Extracellular vesicles (EVs) provide a novel source of valuable biomarkers that may…
  • 2020 American Transplant Congress

    Activation of YAP Attenuates Hepatic Damage and Fibrosis in Liver Ischemia-Reperfusion Injury: From Bench to Bedside

    Y. Liu1, T. Lu2, C. Zhang1, Z. Xue1, R. Busuttil1, J. Kupiec-Weglinski1, H. Ji1

    1Dumont-UCLA Transplant Center, Los Angeles, CA, 2Shanghai Jiaotong University, Shanghai, China

    *Purpose: Hepatic ischemia-reperfusion injury (IRI) is a major complication of hemorrhagic shock, liver resection and transplantation. YAP, the effector of Hippo pathway, is essential in…
  • 2020 American Transplant Congress

    Liver Transplant Recipients with High DSA at Time of Transplant Do Not Have Increased Rejection or Mortality

    A. Demirag1, B. Rawashdeh1, S. L. Lennon1, S. Pelletier1, J. Iezzoni2, K. Khutsisvhili3, S. Shumilina1, K. Chittum1, J. Oberholzer1, P. Lobo4

    1Department of Surgery, University of Virginia Medical Cener, Charlottesville, VA, 2Department of Pathology, University of Virginia Medical Cener, Charlottesville, VA, 3Histocompatibility Laboratory, University of Virginia Medical Cener, Charlottesville, VA, 4Department of Medicine, University of Virginia Medical Cener, Charlottesville, VA

    *Purpose: Currently, there is controversy regarding transplanting livers in setting of high HLA-class ll DSA especially since prior studies demonstrated enhanced acute rejections in this…
  • 2020 American Transplant Congress

    Platelets Stimulate Liver Regeneration in a 30% Partial Liver Transplantation Model in Rat

    K. Takahashi, C. Liang, N. Ohkohchi, T. Oda

    University of Tsukuba, Tsukuba, Japan

    *Purpose: Liver transplantation (LT) is one of the most definitive treatments for patients with end-stage liver disease and acute liver failure, and it has been…
  • 2020 American Transplant Congress

    New IGL-2 Perfusate in Liver HOPE Strategies

    A. Panisello-Rosello1, C. Castro-Benítez2, E. Folch-Puy1, J. Rosello-Catafau1, R. Adam2

    1Experimental Pathology, Instituto de Investigaciones Biomedicas de Barcelona, Barcelona, Spain, 2Centre Hépato-Billiare, Hôpital Paul Brousse, Paris, France

    *Purpose: HOPE has shown to optimize graft liver preservation. However, the most used perfusion solutions as such as Belzer-MPS and its generics were initially for…
  • 2020 American Transplant Congress

    Simultaneous Liver and Kidney Transplant Outcomes after “Safety Net” Policy Change

    D. Keys1, T. Leventhal1, S. Jackson1, S. Riad1, R. Spong1, A. Matas1, J. Rao2

    1University of Minnesota, Minneapolis, MN, 2Surgery, University of Minnesota, Minneapolis, MN

    *Purpose: Criteria for listing for Simultaneous Liver and Kidney (SLK) transplant changed on August 10, 2017. These changes were implemented to standardize the criteria for…
  • 2020 American Transplant Congress

    Uncontrolled DCD vs DBD Liver Transplantation in the United States: Is it Safe to Push the Envelope?

    R. A. Choudhury1, D. Yoeli1, H. Yaffe1, H. B. Moore1, G. Hoeltzel2, A. Schulick1, K. D. Conzen1, J. J. Pomposelli1, E. A. Pomfret1, T. L. Nydam1

    1Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, 2Thomas Jefferson University Hospital, Philadelphia, PA

    *Purpose: Uncontrolled donation after cardiac death (uDCD) liver transplantation has been theorized as a potential option to increase the donor pool due to the typical…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 20
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences